Back to results
US 8,716,450 B2Granted
Dual variable domain immunoglobulins and uses thereof
AssigneeAbbVie Inc.
InventorsTariq Ghayur, Rajesh V. Kamath, Junian Liu, Marie P. Honore
Life of this patent
Estimating the term…
Abstract
The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.
Claims23
A binding protein comprising first and second polypeptide chains, each independently comprising VD1-(X1)n-VD2-C-(X2)n, wherein
- VD1 is a first variable domain;
- VD2 is a second variable domain;
- C is a constant domain;
- X1 is a linker;
- X2 is an Fc region;
- and
- n is 0 or 1;
- wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding NGF and PGE2, wherein
- (1) the variable domains that form a functional target binding site for NGF comprise CDRs 1-3 from SEQ ID NO:
- 38 and CDRs 1-3 from SEQ ID NO:
- 39;
- and
- (2) the variable domains that form a functional target binding site for PGE2 comprise CDRs 1-3 from SEQ ID NO:
- 32 and CDRs 1-3 from SEQ ID NO:
- 33.
12 more elements
A binding protein comprising first and second polypeptide chains, each independently comprising VD1-(X1)n-VD2-C-(X2)n, wherein
- VD1 is a first variable domain;
- VD2 is a second variable domain;
- C is a constant domain;
- X1 is a linker;
- X2 is an Fc region;
- and
- n is 0 or 1;
- wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding NGF and PGE2, wherein
- (1) the variable domains that form a functional target binding site for NGF comprise SEQ ID NO:
- 38 and/or SEQ ID NO:
- 39;
- and
- (2) the variable domains that form a functional target binding site for PGE2 comprise SEQ ID NO:
- 32 and/or SEQ ID NO:
- 33.
12 more elements
A binding protein capable of binding NGF and PGE2, wherein the binding protein comprises:
- DVD933 (comprising SEQ ID NOs:
- 48 and 49),
- DVD934 (comprising SEQ ID NOs:
- 50 and 51),
- DVD935 (comprising SEQ ID NOs:
- 52 and 53),
- DVD936 (comprising SEQ ID NOs:
- 54 and 55),
- DVD937 (comprising SEQ ID NOs:
- 56 and 57),
- DVD938 (comprising SEQ ID NOs:
- 58 and 59),
- DVD939 (comprising SEQ ID NOs:
- 60 and 61), or
- DVD940 (comprising SEQ ID NOs:
- 62 and 63).
13 more elements
Dependencies are inferred from the claim text.